Published in Contrib Nephrol on January 01, 1984
Angiotensin-converting enzyme inhibitors in chronic renal failure. Drugs (1990) 0.75
Report of the Radionuclides in Nephrourology Committee on renal clearance. J Nucl Med (1996) 1.98
Renal protective effect of enalapril in diabetic nephropathy. BMJ (1992) 1.88
Consensus report on ACE inhibitor renography for detecting renovascular hypertension. Radionuclides in Nephrourology Group. Consensus Group on ACEI Renography. J Nucl Med (1996) 1.87
Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy. Br Med J (Clin Res Ed) (1986) 1.65
Contrasting effects of enalapril and metoprolol on proteinuria in diabetic nephropathy. BMJ (1990) 1.62
Reference values for 51Cr-EDTA clearance as a measure of glomerular filtration rate. Scand J Clin Lab Invest (1981) 1.60
Angiotensin converting enzyme inhibitors and progressive renal insufficiency. Current experience and future directions. Ann Intern Med (1989) 1.53
Reversal of cardiovascular structural changes when treating essential hypertension. The importance of the renin-angiotensin-aldosterone system. Am J Hypertens (1992) 1.48
Apolipoprotein-B-containing lipoproteins and the progression of renal insufficiency. Nephron (1993) 1.42
Captopril effect on hypertension in patient with renin-producing tumour. Lancet (1979) 1.42
Increased systemic and renal vascular sensitivity to angiotensin II in normotensive men with positive family histories of hypertension. Am J Hypertens (1992) 1.39
Blunted renal sodium excretion during acute saline loading in normotensive men with positive family histories of hypertension. Am J Hypertens (1991) 1.39
Consensus on diuresis renography for investigating the dilated upper urinary tract. Radionuclides in Nephrourology Group. Consensus Committee on Diuresis Renography. J Nucl Med (1996) 1.37
Urinary concentration test with desmopressin. Br Med J (1978) 1.34
Autoantibodies against the angiotensin receptor (AT1) in patients with hypertension. J Hypertens (2000) 1.26
Renal function and biopsy findings in patients on long-term lithium treatment. Kidney Int (1981) 1.24
Functional autoimmune epitope on alpha 1-adrenergic receptors in patients with malignant hypertension. Lancet (1994) 1.21
Malignant hypertension--improving prognosis in a rare disease. Acta Med Scand (1979) 1.21
GFR measurement with iohexol and 51Cr-EDTA. A comparison of the two favoured GFR markers in Europe. Nephrol Dial Transplant (1998) 1.19
Effects of captopril in Bartter's syndrome. N Engl J Med (1981) 1.14
Pharmacokinetic and pharmacodynamic properties of metoprolol in patients with impaired renal function. Clin Pharmacokinet (1980) 1.13
Felodipine, an arteriolar dilator with pronounced antihypertensive effect. Lancet (1983) 1.07
Increased sympathetic nerve activity in renovascular hypertension. Circulation (1999) 1.06
Effective dose range of enalapril in mild to moderate essential hypertension. Br J Clin Pharmacol (1985) 1.05
Subjects heterozygous for genetic loss of function of the thiazide-sensitive cotransporter have reduced blood pressure. Hum Mol Genet (2007) 1.04
Lithium-induced uraemia. Lancet (1979) 1.03
The role of beta-1-adrenoceptors in the renin release response to graded renal sympathetic nerve stimulation. Pflugers Arch (1980) 1.01
Renal function in normo- and hypertensive 50-year-old males. Acta Med Scand (1976) 1.00
Physical activity, physical fitness and risk of myocardial infarction. Adv Cardiol (1976) 0.95
Captopril treatment of hypertension and renal failure in systemic lupus erythematosus. Nephron (1984) 0.95
Autoantibodies against cardiac G-protein-coupled receptors define different populations with cardiomyopathies but not with hypertension. Clin Immunol Immunopathol (1994) 0.95
Renin secretion in advanced diabetic nephropathy. Scand J Urol Nephrol Suppl (1984) 0.94
Renal and hemodynamic effects of isradipine in essential hypertension. Am J Med (1989) 0.94
Kidney damage in long-term lithium patients: a cross-sectional study of patients with 15 years or more on lithium. Nephrol Dial Transplant (1994) 0.93
Serum lipids and lipoproteins during long-term administration of an oral contraceptive. Lancet (1966) 0.93
Treatment of renovascular hypertension: one year results of renal angioplasty. Kidney Int (1995) 0.93
Blood pressure and renal function. Acta Med Scand (1980) 0.92
Diabetic nephropathy: is dietary protein harmful? J Diabet Complications (1988) 0.92
The effect of impaired renal function on the plasma concentration and urinary excretion of metoprolol metabolites. Clin Pharmacokinet (1980) 0.92
Immunological changes in patients with previous malignant essential hypertension. Lancet (1981) 0.91
Procedure guideline for diagnosis of renovascular hypertension. Society of Nuclear Medicine. J Nucl Med (1998) 0.91
Characterization of inactive renin ("prorenin") from renin-secreting tumors of nonrenal origin. Similarity to inactive renin from kidney and normal plasma. J Clin Invest (1984) 0.91
Grapefruit juice: a possible source of variability in blood concentration of cyclosporin A. Nephrol Dial Transplant (1993) 0.91
Antazoline-induced immune hemolytic anemia, hemoglobinuria, and acute renal failure. Acta Med Scand (1975) 0.90
Differential effects of captopril and enalapril, two angiotensin converting enzyme inhibitors, on immune reactivity in experimental lupus disease. Agents Actions (1990) 0.89
Biochemical and immunological characterization of ectopic tumoral renin. J Clin Endocrinol Metab (1982) 0.89
Evaluation of duplex ultrasound and captopril renography for detection of renovascular hypertension. Kidney Int (2000) 0.89
Renal function on and off lithium in patients treated with lithium for 15 years or more. A controlled, prospective lithium-withdrawal study. Nephrol Dial Transplant (1996) 0.88
Nine years' follow-up of a maximal exercise test in a random population sample of middle-aged men. Cardiology (1981) 0.88
Drug-induced diabetes insipidus: incidence, prevention and management. Drug Saf (1999) 0.88
Effects of metoprolol and propranolol on furosemide-stimulated renin release in healthy subjects. Eur J Clin Pharmacol (1975) 0.87
The role of prostaglandins in the alpha- and beta-adrenoceptor mediated renin release response to graded renal nerve stimulation. Pflugers Arch (1981) 0.87
Sodium excretion and blood pressure. Hypertension (1981) 0.87
Rhabdomyolysis and acute renal failure associated with influenza virus type A. Scand J Urol Nephrol (1999) 0.87
Acute renal failure after analgesic drugs including paracetamol (acetaminophen). Nephron (1988) 0.86
A historical cohort study of kidney damage in long-term lithium patients: continued surveillance needed. Eur Psychiatry (2001) 0.86
Advanced diabetic glomerulopathy. Quantitative structural characterization of nonoccluded glomeruli. Diabetes (1987) 0.86
Salt intake in young Swedish men. Public Health Nutr (2009) 0.85
Late results of pyeloplasty for idiopathic hydronephrosis in adults. Scand J Urol Nephrol (1983) 0.85
A platelet aggregation inhibitor--ticlopidine--in diabetic nephropathy: a randomized double blind study. Clin Nephrol (1984) 0.84
Effects of cardiopulmonary bypass and prostacyclin on plasma catecholamines, angiotensin II and arginine-vasopressin. Acta Anaesthesiol Scand (1985) 0.84
Impairment of renal function in patients on long-term lithium treatment. Clin Nephrol (1982) 0.83
Renal sensitivity to angiotensin II in type 1 diabetes. Scand J Urol Nephrol (1990) 0.83
The effects of an ACE inhibitor and a calcium antagonist on the progression of renal disease: the Nephros Study. Nephrol Dial Transplant (2001) 0.83
Experimental and clinical results of continuous hypothermic albumin perfusion. Proc Eur Dial Transplant Assoc (1972) 0.82
Immunosuppressive action of captopril blocked by prostaglandin synthetase inhibitor. Lancet (1981) 0.82
Predictors and evolution of renal function during 9 years following heart transplantation. J Am Soc Nephrol (2000) 0.82
Kidney function in an unselected lithium population. A cross-sectional study. Acta Psychiatr Scand (1983) 0.82
Extracorporeal immunoadsorption of anti-HLA antibodies: preliminary clinical experience. Transplant Proc (1987) 0.81
Renal function studies after donor nephrectomy. Scand J Urol Nephrol (1976) 0.81
Increased cardiovascular mortality in hypertensive patients with renal artery stenosis. Relation to sympathetic activation, renal function and treatment regimens. J Hypertens (1999) 0.81
Deformability and electrolyte changes of erythrocytes in connection with open heart surgery. Scand J Thorac Cardiovasc Surg (1986) 0.81
Renal effects of felodipine in hypertensive patients with reduced renal function. Drugs (1985) 0.81
Determination of glomerular filtration rate in advanced renal insufficiency. Scand J Urol Nephrol (1978) 0.80
Oxidative stress and endothelin-1 in atherosclerotic renal artery stenosis and effects of renal angioplasty. Kidney Blood Press Res (2011) 0.80
Intense sympathetic nerve activity in adults with hypopituitarism and untreated growth hormone deficiency. J Clin Endocrinol Metab (1998) 0.80
Antidiuretic hormone levels and the effect of indomethacin on ureteral colic. J Urol (1983) 0.80
Renovascular resistance in primary hypertension: experimental variations detected by means of Doppler ultrasound. J Hypertens (1994) 0.80
Renal response in man to plasma volume expansion and angiotensin. Scand J Clin Lab Invest Suppl (1969) 0.80
Influence of age on the response to increased salt intake: effects on blood pressure and sodium in erythrocytes. J Hypertens Suppl (1983) 0.80
Relationship between anti-neutrophil cytoplasmic antibody determined with conventional binding and the capture assay, and long-term clinical course in vasculitis. J Intern Med (2002) 0.80
Extracorporeal ("ex vivo") connection of pig kidneys to humans. I. Clinical data and studies of platelet destruction. Xenotransplantation (1996) 0.80
Serum lipids and lipoproteins in human pregnancy. Clin Chim Acta (1966) 0.80
Renal extraction ratios for 51Cr-EDTA, PAH, and glucose in early insulin-dependent diabetic patients. Kidney Int (1982) 0.80
Hemoperfusion with Amberlite resin in the treatment of self-poisoning. Acta Med Scand (1980) 0.80
Angiotensin-converting enzyme gene I/D polymorphism in malignant hypertension. Blood Press (2000) 0.79